Health In Tech Registers 34.2M Yorkville Shares — 39% Dilution Now Tradable
HIT is trading near its 52-week low of $0.614 (5.0% above the low) on light trading volume (0.1× avg).
Summary
Health In Tech registered 34.2M shares for Yorkville's resale — 39% of shares outstanding — making its standby equity line tradable. The company nets nothing from resales and must use advances to repay the convertible notes first.
Key Events · Financing and Capital Events · HIT
-
34.2M Yorkville Shares Registered for Resale
The prospectus covers 9,532,889 conversion shares and 24,691,358 advance shares. If all were issued they would equal 39.0% of the 53,600,790 shares outstanding and 62.3% of the 20,690,341 non-affiliate shares as of October 6, 2026.
-
Company Gets No Resale Proceeds
Health In Tech receives $0 from Yorkville's sales. It may draw up to $20.0M under the SEPA, but while convertible notes are outstanding every advance is automatically applied to repay them.
-
Conversion Price Far Above Market
Notes convert at a fixed $1.5735 versus the $0.65 close on October 16, 2026. Advances instead price at 97% of the lowest VWAP over a three-day pricing period, so equity-line sales come at a discount to market.
-
Exchange Cap Blocks Full Issuance Until Vote
Nasdaq rules cap issuance at 13,100,378 shares (19.99%) until shareholders approve more at the November 10, 2026 annual meeting. A 4.99% beneficial ownership limit also applies.
Analysis · HIT · Finance
This final prospectus turns the Yorkville standby equity deal from a disclosed plan into shares that can actually hit the market. Up to 34,224,247 shares are registered for resale — 39.0% of the 53.6M shares outstanding and 62.3% of the 20.7M non-affiliate float if every share is issued. The company gets no proceeds from Yorkville's resales; it can only draw up to $20M under the SEPA, and until the convertible notes are repaid every advance is automatically applied to that debt rather than to operations. The notes convert at a fixed $1.5735, roughly 2.4x the $0.65 close on October 16, 2026, so at today's price Yorkville has little incentive to convert and the equity line is the more likely funding path — at 97% of the lowest VWAP, meaning shares are sold at a discount to whatever the market prints. A 19.99% exchange cap (13,100,378 shares) blocks full issuance until shareholders vote November 10 to lift it, and the second $3M note tranche ($2.85M net) is due the later of October 21, 2026 or two trading days after this registration goes effective. Against a Q2 net loss of $2.5M and negative operating cash flow, this is survival capital raised on terms that shift real value to Yorkville.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 37.9% of the 895 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.87%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HIT was trading at $0.64 on NASDAQ in the Finance sector, with a market capitalization of approximately $42.6M. The 52-week trading range was $0.61 to $3.54. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.